Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer

Autor: Wu Y, Lv Tf, Gu Xl, Li Yf, Yuan Dm, Ma Xq, Song Y, Xiao Yy, Liu Hb

Publikováno v: Neoplasma. 60(2)

Recent studies have shown an indirect link between platelet count and blood vessel metastasis, but this association with lymphatic vessels metastasis has not been established in NSCLC. So we investigated whether an association exists between preopera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cec54a975965c119a2b1547ff17ce9e4
https://pubmed.ncbi.nlm.nih.gov/23259790

Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study.

Autor: Xu CW; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China., Wang WX; Department of Medical Oncology, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou China., Wang D; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China., Wang QM; Department of Internal Medicine, the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China., Pu XX; Department of Medical Oncology, Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China., Zhu YC; Department of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, China., Huang JH; Department of Oncology, Lishui Municipal Central Hospital, Lishui, China., Yu ZY; Department of Medical Oncology, the 900th Hospital of the Joint Logistics Team (the Former Fuzhou General Hospital), Fujian Medical University, Fuzhou, China., Cui ZL; Department of Clinical Laboratory, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, China., Chen XH; Department of Thoracic Surgery, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, China., Li JL; Department of Radiotherapy, Xiamen Cancer Hospital, the First Affiliated Hospital of Xiamen University, Xiamen, China., Fang Y; Department of Oncology, Sir Run Run Shaw Hospital, Hangzhou, China., Wang H; Department of Lung Cancer, the Fifth Medical Center, General of PLA, Beijing, China., Zhuang W; Department of Medical Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China., Lan SJ; Department of Oncology, the First Hospital of Jilin University, Changchun, China., Cai X; Department of Oncology, the First Affiliated Hospital of Dalian Medical University, Dalian, China., Zhang YB; Department of Oncology, the Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, China., Gao WB; Department of Oncology, Shenzhen Luohu People's Hospital, Shenzhen Guangdong, China., Wang LP; Department of Oncology, Baotou Cancer Hospital, Baotou, China., She KL; Department of Thoracic Surgery, the Central Hospital of Shaoyang City, Shaoyang, China., Rao CZ; Department of Radiation and Chemotherapy, Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, China., Zhou YF; Department of Oncology, Lishui Municipal Central Hospital, Lishui, China., Fang MY; Department of Medical Oncology, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou China., Miao LY; Department of Respiratory Medicine, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China., Lei L; Department of Medical Oncology, Chinese Academy of Sciences University Cancer Hospital (Zhejiang Cancer Hospital), Hangzhou China., Lv TF; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China., Song Y; Department of Respiratory Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.

Publikováno v: Translational lung cancer research [Transl Lung Cancer Res] 2020 Oct; Vol. 9 (5), pp. 1853-1861.

LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling.

Autor: Zhao M; Department of Respiratory Medicine, Jinling Hospital, Second Military Medical University, Nanjing, China., Xin XF; Department of Respiratory Medicine, Jinling Hospital, Second Military Medical University, Nanjing, China., Zhang JY; Department of Respiratory Medicine, Jinling Hospital, Second Military Medical University, Nanjing, China., Dai W; Department of Respiratory Medicine, Jinling Hospital, Second Military Medical University, Nanjing, China., Lv TF; Department of Respiratory Medicine, Jinling Hospital, Second Military Medical University, Nanjing, China., Song Y; Department of Respiratory Medicine, Jinling Hospital, Second Military Medical University, Nanjing, China.

Publikováno v: Cancer medicine [Cancer Med] 2020 Feb; Vol. 9 (3), pp. 1196-1208. Date of Electronic Publication: 2019 Dec 20.

Geranylgeranyl diphosphate synthase 1 knockout ameliorates ventilator-induced lung injury via regulation of TLR2/4-AP-1 signaling.

Autor: Wan B; Department of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, 210002, China., Xu WJ; Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, 210002, China., Chen MZ; Department of General Internal Medicine, The First People's Hospital of Chenzhou, Chenzhou, 423000, China., Sun SS; Department of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, 210002, China., Jin JJ; Department of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, 210002, China., Lv YL; Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, 210002, China., Zhan P; Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, 210002, China., Zhu SH; Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, 210002, China., Wang XX; Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, 210002, China., Lv TF; Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, 210002, China. Electronic address: bairoushui@163.com., Song Y; Department of Respiratory and Critical Medicine, Jinling Hospital, Nanjing Clinical School of Southern Medical University, Nanjing, 210002, China. Electronic address: yong_song6310@yahoo.com.

Publikováno v: Free radical biology & medicine [Free Radic Biol Med] 2020 Feb 01; Vol. 147, pp. 159-166. Date of Electronic Publication: 2019 Dec 24.

Real-world efficacy and potential mechanism of resistance of icotinib in Asian advanced non-small cell lung cancer with EGFR uncommon mutations: A multi-center study.

Autor: Lei L; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, People's Republic of China., Wang WX; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, People's Republic of China., Zhu YC; Department of Thoracic Disease Center, Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, People's Republic of China., Li JL; Department of Radiotherapy, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, People's Republic of China., Fang Y; Department of Oncology, Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, People's Republic of China., Wang H; Department of Lung Cancer, The Fifth Medical Center, General of PLA, Beijing, People's Republic of China., Zhuang W; Department of Medical Oncology, Fujian Provincial Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, People's Republic of China., Zhang YB; Department of Oncology, The Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China., Wang LP; Department of Oncology, Baotou Cancer Hospital, Baotou, Inner Mongolia, People's Republic of China., Fang MY; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, People's Republic of China., Xu CW; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, People's Republic of China., Wang XJ; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, People's Republic of China., Lv TF; Department of Respiratory Medicine, Jinling Hospital, Nanjing, Jiangsu, People's Republic of China., Song Y; Department of Respiratory Medicine, Jinling Hospital, Nanjing, Jiangsu, People's Republic of China.

Publikováno v: Cancer medicine [Cancer Med] 2020 Jan; Vol. 9 (1), pp. 12-18. Date of Electronic Publication: 2019 Nov 06.